|
|
40
|
|
|
4291V
|
|
|
VANCOMYCIN 500MG INJ (FSB/ATB)
|
|
|
VANCOMYCIN
|
|
|
VANCOMYCIN
|
|
|
500MG VIAL
|
|
|
BQ
|
|
|
4.08
|
|
|
4.08
|
|
|
500MG
|
|
|
INJECTION
|
|
|
0
|
|
|
VIAL
|
|
|
FSB
|
|
|
FLAGSHIP BIOTECH
|
|
|
ATB
|
|
|
ANSA TRADING BARBADOS LTD
|
|
|
|
|
|
Anti-Neoplastic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
08122816
|
|
|
GLYCOPEPTIDES
|
|
|
|
|
|
IV
|
|
|
6
|
|
|
ANTI-INFECTIVE AGENTS
|
|
|
|